Tag anti caner drug

  Trastuzumab biosimilar launched but still priced out of reach for most patients New Delhi, 18 January 2014   The Campaign for Affordable Trastuzumab welcomes the announcement by Biocon of the release of CANMAb, a biosimilar of trastuzumab. CANMAb is… Continue Reading →